Iperia 5 HF-T QP/HF-T

Iperia 5 HF-T QP CRT-D
Iperia 5 HF-T QP
Iperia 5 HF-T CRT-D
Iperia 5 HF-T
Iperia 5 HF-T CRT-D
Iperia 5 HF-T
Iperia 5 HF-T QP CRT-D
Iperia 5 HF-T QP
Iperia 5 HF-T CRT-D
Iperia 5 HF-T
Iperia 5 HF-T CRT-D
Iperia 5 HF-T

Iperia 5 HF-T

Bringing Quality to Life

The Iperia 5 CRT-D series with BIOTRONIK Home Monitoring®, ProMRI® and quadripolar LV pacing enables multiple left-ventricular pacing and sensing configurations for CRT management, offering solutions that improve quality of life and reduce mortality in heart failure patients.1

Key facts
  • BIOTRONIK Home Monitoring enables wireless patient monitoring, including Home Monitoring-supported follow-ups with remote scheduling, for the early detection of clinical and device-related events
  • ProMRI allows patients to undergo MRI scanning under specific conditions
  • Quadripolar LV pacing enables multiple left-ventricular pacing and sensing configurations for CRT management
  • Its small size and reduced thickness increases patient comfort
  • The Heart Failure Monitor enables the early detection of changes in patients’ heart failure conditions with the continuous monitoring of clinical parameters
  • The DF4 connector simplifies and shortens the implantation procedure and reduces material in the device pocket
Product Manual Iperia 5 HF-T QP/HF-T

Product Features

Long-Lasting Products

Long-Lasting Products

BIOTRONK CRT-Ds provide up to 7.5 years of longevity, reducing device replacements and their associated risks.

Increased Lifetime

Increased Lifetime

BIOTRONIK CRT-Ds provide automatic, daily implant-based remote monitoring, leading to a more than 50% reduction in mortality for heart failure patients, as proven by the IN-TIME trial.1

BioMonitor ProMRI

Verified MRI Access

BIOTRONIK CRT-Ds feature full-body MRI scan options to improve the diagnosis of non-cardiac comorbidities in heart failure patients.

Early Detection

Early Detection

BIOTRONIK Home Monitoring provides reliable daily transmissions so you can treat heart failure patients according to ESC guidelines.2 Earlier detection of clinical problems reduces inappropriate shocks2 and increases patients' lifetimes.1

Avoiding Inappropriate Shocks

Shock Reduction

BIOTRONIK CRT-Ds with Home Monitoring reduce the number of patients who receive inappropriate shocks by 52%, as proven by the ECOST trial.3

Product Details

Flexibility in LV Pacing

Flexibility in Pacing the LV

MultiSelect LV offers electronic repositioning options to select the optimal stimulation site, manage phrenic nerve stimulation and achieve an excellent pacing threshold to improve CRT therapy.

Physician and nurse are looking at the patient status on the HMSC

BIOTRONIK Home Monitoring

BIOTRONIK Home Monitoring is a remote monitoring service available with cardiac monitors, pacemakers, implantable defibrillators (ICDs) and cardiac resynchronization therapy (CRT) systems. Home Monitoring allows physicians to continuously and reliably survey patients’ device and physiological condition, and alerts responsible healthcare staff of acute health changes within 24 hours. Click Here for more information

ProMRI

ProMRI

ProMRI technology offers patients safe access to MRIs under certain conditions. Click Here for more information

contact

1 Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. The Lancet. 2014; 384 (9943): 583–590.

2 Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. European Heart Journal. 2013; 34: 2281–2329.

3 Guédon-Moreau L, Lacroix D, Sadoul N, et al. A randomized study of remote follow-up of implantable defibrillators: Safety and efficacy report of the ECOST trial. Eur Heart J. 2013; 34: 605–614.